Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Recommendation of “Hold” by Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus rating of “Hold” from the four analysts that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $4.00.

BIOX has been the subject of several analyst reports. Wall Street Zen cut Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th. Weiss Ratings cut Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Wednesday, May 6th.

Bioceres Crop Solutions Trading Down 4.5%

Shares of NASDAQ BIOX opened at $0.43 on Friday. Bioceres Crop Solutions has a twelve month low of $0.35 and a twelve month high of $5.18. The company has a current ratio of 0.88, a quick ratio of 0.69 and a debt-to-equity ratio of 0.57. The stock has a fifty day simple moving average of $0.50 and a 200-day simple moving average of $1.00. The stock has a market capitalization of $27.13 million, a PE ratio of -0.11 and a beta of 0.39.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.11). Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. The firm had revenue of $39.40 million during the quarter, compared to analyst estimates of $54.50 million. On average, equities analysts forecast that Bioceres Crop Solutions will post -0.16 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. acquired a new position in Bioceres Crop Solutions during the 4th quarter worth $45,000. Ardsley Advisory Partners LP grew its stake in Bioceres Crop Solutions by 691.7% during the 4th quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock worth $622,000 after purchasing an additional 415,000 shares in the last quarter. GAM Holding AG acquired a new position in Bioceres Crop Solutions during the 4th quarter worth $655,000. State of Wisconsin Investment Board acquired a new position in Bioceres Crop Solutions during the 4th quarter worth $247,000. Finally, Marshall Wace LLP boosted its position in shares of Bioceres Crop Solutions by 180.0% during the 4th quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after acquiring an additional 382,744 shares in the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.